SI1150970T1 - Derivati (1-fenacil-3-fenil-3-piperidiletil)piperidina, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo - Google Patents

Derivati (1-fenacil-3-fenil-3-piperidiletil)piperidina, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo

Info

Publication number: SI1150970T1
Authority: SI; Slovenia
Prior art keywords: phenacy; piperidylethyl; phenyl; production; pharmaceutical compositions
Prior art date: 1999-02-10

Application number

SI200030968T

Other languages

English (en)

Inventor

Jean Philippe Ducoux

Xavier Emonds-Alt

Patrick Gueule

Vincenzo Proietto

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-10

Filing date

2000-02-08

Publication date

2008-02-29

1999-02-10 Priority claimed from FR9901593A external-priority patent/FR2789389B3/fr

2000-02-08 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2008-02-29 Publication of SI1150970T1 publication Critical patent/SI1150970T1/sl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

SI200030968T 1999-02-10 2000-02-08 Derivati (1-fenacil-3-fenil-3-piperidiletil)piperidina, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo SI1150970T1 (sl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FR9901593A FR2789389B3 (fr)	1999-02-10	1999-02-10	Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
FR9904429A FR2789390B3 (fr)	1999-02-10	1999-04-07	Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
EP00903744A EP1150970B1 (fr)	1999-02-10	2000-02-08	Derives de (1-phenacy-3-phenyl-3-piperidylethyl)piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
PCT/FR2000/000284 WO2000047572A1 (fr)	1999-02-10	2000-02-08	Derives de (1-phenacy-3-phenyl-3-piperidylethyl)piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant

Publications (1)

Publication Number	Publication Date
SI1150970T1 true SI1150970T1 (sl)	2008-02-29

Family

ID=26234812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200030968T SI1150970T1 (sl)	1999-02-10	2000-02-08	Derivati (1-fenacil-3-fenil-3-piperidiletil)piperidina, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo

Country Status (37)

Country	Link
US (2)	US6642233B1 (sl)
EP (1)	EP1150970B1 (sl)
JP (1)	JP4648544B2 (sl)
KR (1)	KR100611261B1 (sl)
CN (1)	CN1273463C (sl)
AR (1)	AR028813A1 (sl)
AT (1)	ATE370942T1 (sl)
AU (1)	AU763716B2 (sl)
BG (1)	BG65031B1 (sl)
BR (1)	BR0008067A (sl)
CA (1)	CA2360894C (sl)
CO (1)	CO4980896A1 (sl)
CZ (1)	CZ300765B6 (sl)
DE (1)	DE60036081T2 (sl)
DK (1)	DK1150970T3 (sl)
EE (1)	EE04437B1 (sl)
ES (1)	ES2291187T3 (sl)
FR (1)	FR2789390B3 (sl)
HK (1)	HK1038927A1 (sl)
HR (1)	HRP20010566A2 (sl)
HU (1)	HUP0201281A3 (sl)
ID (1)	ID29219A (sl)
IL (2)	IL144363A0 (sl)
ME (1)	MEP11908A (sl)
NO (2)	NO321149B1 (sl)
NZ (1)	NZ513053A (sl)
PE (1)	PE20001463A1 (sl)
PL (1)	PL198561B1 (sl)
PT (1)	PT1150970E (sl)
RS (1)	RS50210B (sl)
RU (1)	RU2220956C2 (sl)
SI (1)	SI1150970T1 (sl)
SK (1)	SK286401B6 (sl)
TR (1)	TR200102331T2 (sl)
TW (1)	TWI254712B (sl)
UA (1)	UA70986C2 (sl)
WO (1)	WO2000047572A1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003070745A2 (en) *	2002-02-20	2003-08-28	Sepracor Inc.	Carbonate and carbamate modified forms of glucocorticoids
US20050009798A1 (en)	2002-02-20	2005-01-13	Sepracor Inc.	Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
JP2007519702A (ja) *	2004-01-30	2007-07-19	ファイザー・プロダクツ・インク	ニューロキニン受容体拮抗薬及びシクロデキストリンからなる医薬組成物、ならびに注射部位の耐容性を改善するための方法
FR2873373B1 (fr) *	2004-07-23	2006-09-08	Sanofi Synthelabo	Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
GB2452696B (en) *	2007-08-02	2009-09-23	Cambridge Entpr Ltd	3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
DE102008015426A1 (de) *	2008-03-20	2009-09-24	Beiersdorf Ag	Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen
DE102008015425A1 (de) *	2008-03-20	2010-01-21	Beiersdorf Ag	Kosmetische oder dermatologische Zubereitungen zur Verringerung von Juckreiz und anderen dermatologischen Missempfindungen, die insbesondere bei Altershaut auftreten können, mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid
DE102008015428A1 (de) *	2008-03-20	2009-09-24	Beiersdorf Ag	Kühlende Zubereitungen für den humanen Haut- und/oder Schleimhautkontakt mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US512901A (en) *		1894-01-16		Folding bed
GB821012A (en) *	1957-01-15	1959-09-30	Rhone Poulenc Sa	New phenthiazine derivatives and processes for their preparation
FR2676055B1 (fr)	1991-05-03	1993-09-03	Sanofi Elf	Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
AU693936B2 (en)	1994-08-25	1998-07-09	Merrell Pharmaceuticals Inc.	Novel substituted piperidines useful for the treatment of allergic diseases
EP0714891A1 (en) *	1994-11-22	1996-06-05	Eli Lilly And Company	Heterocyclic tachykinin receptor antagonists

1999
- 1999-04-07 FR FR9904429A patent/FR2789390B3/fr not_active Expired - Lifetime
2000
- 2000-02-08 HU HU0201281A patent/HUP0201281A3/hu unknown
- 2000-02-08 BR BR0008067-5A patent/BR0008067A/pt not_active Application Discontinuation
- 2000-02-08 DE DE60036081T patent/DE60036081T2/de not_active Expired - Lifetime
- 2000-02-08 TR TR2001/02331T patent/TR200102331T2/xx unknown
- 2000-02-08 CA CA002360894A patent/CA2360894C/en not_active Expired - Fee Related
- 2000-02-08 KR KR1020017009983A patent/KR100611261B1/ko not_active IP Right Cessation
- 2000-02-08 NZ NZ513053A patent/NZ513053A/xx not_active IP Right Cessation
- 2000-02-08 IL IL14436300A patent/IL144363A0/xx not_active IP Right Cessation
- 2000-02-08 ID IDW00200101651A patent/ID29219A/id unknown
- 2000-02-08 CN CNB008058261A patent/CN1273463C/zh not_active Expired - Fee Related
- 2000-02-08 CZ CZ20012888A patent/CZ300765B6/cs not_active IP Right Cessation
- 2000-02-08 ES ES00903744T patent/ES2291187T3/es not_active Expired - Lifetime
- 2000-02-08 PL PL350243A patent/PL198561B1/pl not_active IP Right Cessation
- 2000-02-08 WO PCT/FR2000/000284 patent/WO2000047572A1/fr active IP Right Grant
- 2000-02-08 PT PT00903744T patent/PT1150970E/pt unknown
- 2000-02-08 JP JP2000598492A patent/JP4648544B2/ja not_active Expired - Fee Related
- 2000-02-08 DK DK00903744T patent/DK1150970T3/da active
- 2000-02-08 SK SK1139-2001A patent/SK286401B6/sk not_active IP Right Cessation
- 2000-02-08 US US09/913,106 patent/US6642233B1/en not_active Expired - Fee Related
- 2000-02-08 UA UA2001075184A patent/UA70986C2/uk unknown
- 2000-02-08 EE EEP200100417A patent/EE04437B1/xx not_active IP Right Cessation
- 2000-02-08 ME MEP-119/08A patent/MEP11908A/xx unknown
- 2000-02-08 AT AT00903744T patent/ATE370942T1/de not_active IP Right Cessation
- 2000-02-08 RU RU2001121989/04A patent/RU2220956C2/ru not_active IP Right Cessation
- 2000-02-08 AU AU25531/00A patent/AU763716B2/en not_active Ceased
- 2000-02-08 RS YUP-564/01A patent/RS50210B/sr unknown
- 2000-02-08 EP EP00903744A patent/EP1150970B1/fr not_active Expired - Lifetime
- 2000-02-08 SI SI200030968T patent/SI1150970T1/sl unknown
- 2000-02-09 AR ARP000100555A patent/AR028813A1/es active IP Right Grant
- 2000-02-09 TW TW089102106A patent/TWI254712B/zh active
- 2000-02-10 CO CO00008757A patent/CO4980896A1/es unknown
- 2000-02-10 PE PE2000000102A patent/PE20001463A1/es not_active Application Discontinuation
2001
- 2001-07-26 HR HR20010566A patent/HRP20010566A2/hr not_active Application Discontinuation
- 2001-08-08 NO NO20013878A patent/NO321149B1/no not_active IP Right Cessation
- 2001-08-08 BG BG105794A patent/BG65031B1/bg unknown
2002
- 2002-01-29 HK HK02100715A patent/HK1038927A1/xx not_active IP Right Cessation
2003
- 2003-09-16 US US10/663,124 patent/US6951940B2/en not_active Expired - Fee Related
2005
- 2005-04-21 NO NO20051958A patent/NO20051958L/no unknown
2007
- 2007-01-07 IL IL180579A patent/IL180579A0/en unknown

Also Published As

Publication number	Publication date
NO321149B1 (no)	2006-03-27
DK1150970T3 (da)	2007-12-17
YU56401A (sh)	2004-03-12
JP2002536442A (ja)	2002-10-29
UA70986C2 (uk)	2004-11-15
DE60036081D1 (de)	2007-10-04
NO20013878L (no)	2001-10-10
NZ513053A (en)	2002-10-25
CZ300765B6 (cs)	2009-08-05
CZ20012888A3 (cs)	2001-11-14
EP1150970A1 (fr)	2001-11-07
FR2789390B3 (fr)	2001-03-09
HRP20010566A2 (en)	2002-08-31
BG65031B1 (bg)	2006-12-29
US20040072840A1 (en)	2004-04-15
EE04437B1 (et)	2005-02-15
CO4980896A1 (es)	2000-11-27
HUP0201281A3 (en)	2003-05-28
AU2553100A (en)	2000-08-29
RS50210B (sr)	2009-07-15
IL180579A0 (en)	2007-06-03
SK286401B6 (sk)	2008-09-05
KR20010101818A (ko)	2001-11-14
PL198561B1 (pl)	2008-06-30
PE20001463A1 (es)	2001-02-21
BR0008067A (pt)	2001-11-06
CN1345317A (zh)	2002-04-17
ES2291187T3 (es)	2008-03-01
NO20051958L (no)	2001-10-10
AU763716B2 (en)	2003-07-31
DE60036081T2 (de)	2008-05-15
JP4648544B2 (ja)	2011-03-09
HK1038927A1 (en)	2002-04-04
RU2220956C2 (ru)	2004-01-10
US6951940B2 (en)	2005-10-04
PL350243A1 (en)	2002-12-02
AR028813A1 (es)	2003-05-28
EE200100417A (et)	2002-12-16
CN1273463C (zh)	2006-09-06
TR200102331T2 (tr)	2002-03-21
ATE370942T1 (de)	2007-09-15
NO20013878D0 (no)	2001-08-08
FR2789390A1 (fr)	2000-08-11
US6642233B1 (en)	2003-11-04
EP1150970B1 (fr)	2007-08-22
MEP11908A (en)	2010-06-10
KR100611261B1 (ko)	2006-08-10
WO2000047572A1 (fr)	2000-08-17
HUP0201281A2 (en)	2002-09-28
SK11392001A3 (sk)	2002-02-05
PT1150970E (pt)	2007-11-07
CA2360894A1 (en)	2000-08-17
CA2360894C (en)	2009-09-22
TWI254712B (en)	2006-05-11
IL144363A0 (en)	2002-05-23
ID29219A (id)	2001-08-16
BG105794A (en)	2002-05-31

Publication	Publication Date	Title
HUP0000748A2 (en)	2001-03-28	4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
AU4048299A (en)	2000-01-05	Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
HUP0102084A3 (en)	2002-12-28	Quinoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0103224A3 (en)	2002-11-28	Quinoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0204515A3 (en)	2005-04-28	4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP9900120A3 (en)	2001-02-28	Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HUP0003141A3 (en)	2001-04-28	4-phenylpiperidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0203316A3 (en)	2004-07-28	Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
IL150225A0 (en)	2002-12-01	Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof
HUP0201516A2 (en)	2002-08-28	13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0303118A3 (en)	2007-08-28	Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
HUP0203496A3 (en)	2004-01-28	Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof
HUP0201753A3 (en)	2004-12-28	Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203184A3 (en)	2004-12-28	Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
IL180579A0 (en)	2007-06-03	Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
HUP0202731A3 (en)	2003-10-28	O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0400549A3 (en)	2004-09-28	Novel imidazole derivatives, production method thereof and pharmaceutical compositions containing them
HUP0105479A3 (en)	2002-06-28	Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them
IL158660A0 (en)	2004-05-12	Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
HUP0200928A3 (en)	2004-07-28	Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
HUP0201916A3 (en)	2003-05-28	Ethanesulfonyl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0003861A3 (en)	2002-09-30	Quinolin-4-yl derivatives, process for producing them and pharmaceutical compositions containing them
HUP9800707A3 (en)	1999-06-28	Phenoxymethyl piperidine derivatives, process for producing them, and pharmaceutical compositions containing them
HUP0201863A3 (en)	2003-03-28	Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing the same
HUP0202106A2 (en)	2002-10-28	Thienopyranecarboxamide derivatives, process for the preparation thereof, pharmaceutical compositions containing them